Last Updated: September 24, 2026

TECHNETIUM TC-99M PENTETATE KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Technetium Tc-99m Pentetate Kit, and what generic alternatives are available?

Technetium Tc-99m Pentetate Kit is a drug marketed by Curium and Ge Healthcare and is included in two NDAs.

The generic ingredient in TECHNETIUM TC-99M PENTETATE KIT is technetium tc-99m pentetate kit. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Technetium Tc-99m Pentetate Kit

A generic version of TECHNETIUM TC-99M PENTETATE KIT was approved as technetium tc-99m pentetate kit by CURIUM on March 26th, 2025.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TECHNETIUM TC-99M PENTETATE KIT?
  • What are the global sales for TECHNETIUM TC-99M PENTETATE KIT?
  • What is Average Wholesale Price for TECHNETIUM TC-99M PENTETATE KIT?
Summary for TECHNETIUM TC-99M PENTETATE KIT
Pharmacology for TECHNETIUM TC-99M PENTETATE KIT
Drug ClassLead Chelator
Mechanism of ActionLead Chelating Activity

US Patents and Regulatory Information for TECHNETIUM TC-99M PENTETATE KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium TECHNETIUM TC-99M PENTETATE KIT technetium tc-99m pentetate kit INJECTABLE;INJECTION 215146-001 Mar 26, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ge Healthcare TECHNETIUM TC-99M PENTETATE KIT technetium tc-99m pentetate kit INJECTABLE;INJECTION 017264-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.